Abstract
AbstractHow will the novel coronavirus evolve? I study a simple epidemiological model, in which mutations may change the properties of the virus and its associated disease stochastically and antigenic drifts allow new variants to partially evade immunity. I show analytically that variants with higher infectiousness, longer disease duration, and shorter latent period prove to be fitter. “Smart” containment policies targeting symptomatic individuals may redirect the evolution of the virus, as they give an edge to variants with a longer incubation period and a higher share of asymptomatic infections. Reduced mortality, on the other hand, does not per se prove to be an evolutionary advantage. I then implement this model as an agent-based simulation model in order to explore its aggregate dynamics. Monte Carlo simulations show that a) containment policy design has an impact on both speed and direction of viral evolution, b) the virus may circulate in the population indefinitely, provided that containment efforts are too relaxed and the propensity of the virus to escape immunity is high enough, and crucially c) that it may not be possible to distinguish between a slowly and a rapidly evolving virus by looking only at short-term epidemiological outcomes. Thus, what looks like a successful mitigation strategy in the short run, may prove to have devastating long-run effects. These results suggest that optimal containment policy must take the propensity of the virus to mutate and escape immunity into account, strengthening the case for genetic and antigenic surveillance even in the early stages of an epidemic.
Publisher
Springer Science and Business Media LLC
Subject
Economics and Econometrics,Business and International Management
Reference51 articles.
1. Basurto A, Dawid H, Harting P, Hepp J, Kohlweyer D (2021) How to design virus containment policies? A joint analysis of economic and epidemic dynamics under the COVID-19 pandemic. Bielefeld working papers in economics and management no. 06–2021
2. Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Ramsay M (2021) Effectiveness of COVID-19 vaccines against the B. 1.617. 2 variant. N Engl J Med 385:585–594
3. Buckee C, Danon L, Gupta S (2007) Host community structure and the maintenance of pathogen diversity. Proc Roy Soc B Biol Sci 274(1619):1715–1721
4. Cao S, Feng P, Wang W, Shi Y, Zhang J (2021) Small-world effects in a modified epidemiological model with mutation and permanent immune mechanism. Nonlinear Dyn, pp 1–16
5. CDC (2021) Covid-19 pandemic planning scenarios. https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html (download on 2nd of July 2021)
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献